Publications by authors named "D Moukassa"

Enteroviruses (EV) initiate replication by binding to their cellular receptors, leading to the uncoating and release of the viral genome into the cytosol of the host cell. Neutralising antibodies (NAbs) binding to epitopes on enteroviral capsid proteins can inhibit this infectious process through several mechanisms of neutralisation in vitro. Fc-mediated antibody effector functions such as antibody-dependent cell-mediated cytotoxicity and antibody-dependent cellular phagocytosis have also been described for some EV.

View Article and Find Full Text PDF
Article Synopsis
  • The study examined the prevalence of high-risk HPV infections and genotype distribution in individuals with normal cervical cytology, along with their vaccination status.
  • A total of 110 cervical samples were tested using the Cepheid GeneXpert system, revealing that 33% were positive for HPV DNA, with HPV16 being the most common type found.
  • Most participants (96.4%) had not received any HPV vaccine, and the few vaccinated individuals still showed HPV infections, highlighting the need for greater public awareness regarding HPV risks.
View Article and Find Full Text PDF

Objectives: Human herpesvirus 8 (HHV8) is rarely studied in Congo, despite its prevalence in Africa. Among healthy individuals, HHV-8 does not always lead to a life-threatening infection; however, in immunocompromised individuals, it could lead to more severe disease. The distribution of HHV-8 genotypes varies depending on ethnicity and geographic region.

View Article and Find Full Text PDF

Sarcoidosis is a multisystem inflammatory disease of unknown etiology. The isolated extrapulmonary form is rare. We report the case of hepatosplenic sarcoidosis in a 29-year-old female patient.

View Article and Find Full Text PDF

Objectives: The HTLV-1 infection persists for life, remaining as asymptomatic viral reservoirs in most patients, ensuring the chain of transmission, but around 4% develop adult T-cell leukemia/lymphoma (ATLL). HTLV-1 is an oncogenic retrovirus that transforms CD4 T lymphocytes and deregulates the lymphoproliferative pathways that contribute to the development of ATLL. To achieve cell transformation, most oncogenic retroviruses use proto-oncogene capture transduction, with proviral integration disrupting the expression of tumor suppressors or proto-oncogenes.

View Article and Find Full Text PDF